JUL 16, 2019 03:18 AM PDT

Rare Bone Marrow Manifestation in Sarcoidosis

WRITTEN BY: Dena Aruta

Sarcoidosis is an inflammatory disease with the hallmark diagnostic feature being non-caseating granulomas--clumps of immune cells including macrophages, epithelial cells, and histiocytes. While 90% of people diagnosed with sarcoidosis have it in their lungs, the disease can affect any organ system in the body. Common extrapulmonary sites include skin, liver, eyes, and lymph nodes. The incidence in the U.S. is approximately is 10 per 100,000 people. The principal investigator, J. Isaac Peña-Garcia, and colleagues, discuss a case study involving a rare manifestation of sarcoidosis in the bone marrow. 

Bone marrow sarcoidosis (BMS) has not been described frequently in the literature. Peña-Garcia cites several studies that illustrate the wide variation in age, gender, and ethnicity, which is common in the involvement of other extrathoracic organs. In a prospective cohort study in which the participants were 95.8% Caucasian, 640 patients were followed over 40 years. None had bone marrow manifestations initially, and at follow up, only 0.3% had BMS. In contrast, in the  ACCESS (A Case-Control Etiologic Study of Sarcoidosis) study, there were 640 patients, of which 44% were African Americans, and 3.9% had BMS. 

In this case study, Peña-Garcia describes a 51-year-old African American woman with a previous diagnosis of cutaneous sarcoidosis. She presented with bilateral knee and lower leg pain as well as paresthesias without neurological involvement. She also had a "low-grade fever, hyporexia with an unintentional 30-pound weight loss over two years, and chronic dry cough." Among the numerous tests performed, a peripheral blood smear showed leukocytopenia and decreased red blood cells. The bone marrow biopsy showed normal cell lineage and non-caseating granulomas consistent with sarcoidosis.

The authors created an algorithm to follow when sarcoidosis patients present with decreased white blood cells and anemia:

Figure 1. A proposed approach to patient with sarcoidosis presenting with cytopenias. Credit  Peña-Garcia et al.

There have been no RCTs that compare different treatments, and to date, no FDA-approved treatment strategies for BMS, but prednisone is the gold standard for treatment of other forms of sarcoidosis. Methotrexate, which is used as a steroid-sparing medication, cannot be used in BMS due to its cytotoxic properties.

 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
AUG 25, 2019
Cell & Molecular Biology
AUG 25, 2019
Could we be allergic to CRISPR?
A new study published in Nature reveals an immunity to the CRISPR-Cas9 proteins in humans...
AUG 25, 2019
Cardiology
AUG 25, 2019
Eel Inspired Battery May Someday Power Pacemakers
The worlds first synthetic battery called a “voltaic stack” was developed by Alessandro Volta, an Italian scientist in 1799. The incredible bod...
AUG 25, 2019
Earth & The Environment
AUG 25, 2019
Temperatures Reach Sweltering Records Throughout Europe
Summer temperatures are soaring throughout Europe, setting records that no one is excited about. During its second heatwave of this summer so far, Paris re...
AUG 25, 2019
Genetics & Genomics
AUG 25, 2019
In a First, Sickle Cell Patient Receives CRISPR Gene Therapy
Many human diseases can be traced back to genetic mutations, and researchers are beginning to find ways to correct those errors....
AUG 25, 2019
Health & Medicine
AUG 25, 2019
Ketamine is not an opioid, and treats depression in a novel way
In March, the U.S. Food and Drug Administration approved ketamine nasal spray to treat depression. Ketamine has gotten a bad rep as an opioid - which it is...
AUG 25, 2019
Immunology
AUG 25, 2019
New Research In Reversing Deafness
Hair cells inside the human ear are responsible for sensing and relaying sound to the brain.  In all mammals except humans, these cells can regenerate...
Loading Comments...